科学健康资讯 · 内容仅供参考,不替代专业诊疗 联系我们|疾病百科
操作系统

apreatherapeutics(

2023-05-09 操作系统 本文链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-031882  Size: 17 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-026159  Size: 4 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001104659-23-008020  Act: 34  Size: 229 KB 网页链接

SIX084:

Aprea Therapeutics(APRE)niu bi

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-008064  Size: 7 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-23-008059  Size: 2 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-23-027442  Act: 34  Size: 214 KB 网页链接

米股阻击手:

Aprea Therapeutics(APRE) newbee

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001104659-23-039155  Act: 34  Size: 7 MB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-23-024314  Act: 33  Size: 403 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-23-019906  Act: 34  Size: 200 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-006624  Act: 34  Size: 80 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-23-031393  Act: 34  Size: 206 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-23-005126  Act: 34  Size: 8 MB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-23-025388  Act: 33  Size: 399 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 8-K Current report, items 5.03, 7.01, and 9.01 Accession Number: 0001104659-23-018997  Act: 34  Size: 234 KB 网页链接

Aprea Therapeutics(APRE):

Aprea Therapeutics(APRE) 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-23-025392  Act: 34  Size: 544 KB 网页链接

本文内容仅供健康科普参考,不能替代专业医疗诊断和治疗建议。如有身体不适,请及时就医并遵从医师指导。

相关阅读